26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
Advances In™: Moving Care Forward in SCLC with DLL3 Targeting Bispecific T-Cell Engagers
View More
Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management
View More
A New Era of Targeted Therapy for Advanced NSCLC: Exploring Future Directions for Bispecific Antibodies and AD...
September 6, 2025
Register Now!
What’s Next for HER2- and TROP2-Directed ADCs in Lung Cancer: How Emerging Trial Data will Impact our Clinics Today, and Tomorrow….
View More
Do We Have Sea Change in Small Cell Lung Cancer? What Recent Clinical Trial Data Tell Us About Treatment Decision-Making in Real-World Settings, What’s Next for Emerging Novel Strategies
View More
Community Practice Connections™: 25th Annual International Lung Cancer Congress
View More
Community Practice Connections™: 8th Annual School of Nursing Oncology™
View More
FDA Accepts Tabelecleucel BLA; Priority Review Granted for Post-Transplant Disease Therapy
The FDA has accepted the resubmitted BLA for tabelecleucel (tab-cel), intended for the treatment of Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD).
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
July 24th 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Gene Therapy for Rare Eye Disease to Advance to Human Trial
July 22nd 2025The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene therapy for boys with blue cone monochromacy, which impairs color vision and severely affects visual function.
Aluminum in Vaccines Does Not Cause Autoimmune Disorders in Children, Study Shows
Autoimmune diseases, such as vitiligo, celiac disease and rheumatoid arthritis, are not tied to aluminum exposure from vaccines, according to a nationwide cohort study of approximately 1.2 million children done in Denmark.